Inflammatory myopathy with abundant macrophages (IMAM): A condition sharing similarities with cytophagic histiocytic panniculitis and distinct from macrophagic myofasciitis

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 5, 2003, Pages 464-474

  Bassez, Guillaume ^a   Authier, Francois Jérôme ^a   Lechapt Zalcman, Emmanuèle ^a   Hélène Delfau Larue, Marie ^b   Plonquet, Anne ^b   Coquet, Michelle ^c   Illa, Isabel ^d   Gherardi, Romain K ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Dermatomyositis; Fasciitis; Hemophagocytic syndrome; Histiocytosis non Langerhans cell; Macrophage; Myositis; Panniculitis

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE;

ADOLESCENT; ADULT; AGED; CHILD; CYTOPHAGIC HISTIOCYTIC PANNICULITIS; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; ERYTHROPHAGOCYTOSIS; FEMALE; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNIZATION; INFLAMMATORY MYOPATHY WITH ABUNDANT MACROPHAGE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MACROPHAGIC MYOFASCIITIS; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE CELL; MYOPATHY; PANNICULITIS; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0038327581     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.5.464     Document Type: Review

References (48)

1. Carpenter S, Karpati G. The pathological diagnosis of specific inflammatory myopathies. Brain Pathol 1992;2:13-19
2. Engel A, Arahata K. Mononuclear cells in myopathies: Quantification of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986;17:704-21
3. Kissel JT, Halterman RK, Rammohan KW, Mendel JR. The relationship of complement-mediated niicrovasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol 1991;48:26-30
4. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;321:1487-98
5. Figarella-Branger D, Lacroix C, Coquet M, Gherardi R, Pellissier JF. Myopathies inflammatoires idiopathiques. Ann Pathol 2001;21: 279-84
6. Gherardi RK, Coquet M, Cherin P, et al. Macrophagic myofasciitis: An emerging entity. Lancet 1998;1;352:347-52
7. Cabello A, Ruiz-Falcò ML, García-Peña JJ, et al. Macrophagic myofasciitis: A new case of non-French origin. Neuropathol Appl Neurobiol 1999;25:S44
8. Navarro C, Rodriguez D, Willisch A, et al. Macrophagic myofasciitis. A report of a new Spanish case. Neuropathol Appl Neurobiol 1999;25:S81
9. Crooks D, Bajalan AAA. Macrophagic, myofasciitis in Britain. Neuropathol Appl Neurobiol 2001;27:158-59
10. Cherin P, Authier FJ, Gherardi RK, et al., Gallium-67 scintigraphy in macrophagic myofasciitis. Arthritis Rheum 2000;43:1520-26
11. INVS, National Institute of Public Health Surveillance in France, http://www.invs.sante.fr/recherche/index2.asp?txtQuery=myofasciite
12. Gherardi RK, Coquet M, Cherin P, et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001;124:1821-31
13. Authier FJ, Chérin P, Créange A, et al. Central nervous system disease in patients with macrophagic myofasciitis. Brain 2001;124: 974-83
14. Guis S, Pellissier JF, Nicoli F, et al. HLA-DRBI*01 and macrophagic myofasciitis. Arthritis Rheum 2002;46:2535-37
15. Authier FJ, Sauvat S, Drogou I, Coquet M, Gherardi RK. Macrophagic myofasciitis (MMF) is a cause of chronic fatigue syndrome (CFS). Arthritis Rheum 2003;48:569-70
16. Craig AJ, Cualing H, Thomas G, Lamerson C, Smith R. Cytophagic histiocytic panniculitis-a syndrome associated with benign and malignant panniculitis: Case comparison and review of the literature. J Am Acad Dermatol 1998;39:721-36
17. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T-cells in the pathogenesis of haemophagocytic syndrome. J Clin Invest 1997;100:1969-79
18. Theodorou I, Bigorgne C, Delfau MH, et al. VJ rearrangements of the TCR gamma locus in peripheral T-cell lymphomas: Analysis by polymerase chain reaction and denaturing gradient gel electrophoresis. J Pathol 1996;178:303-10
19. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. International Chronic Fatigue Syndrome study group. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-59
20. Weber FP, Gray AMH. Chronic relapsing polydermatomyositis with predominant involvement of subcutaneous fat. Br J Dermatol 1924; 36:544-60
21. Janis JF, Winkelmann RK. Histopathology of the skin in dermatomyositis. A histopathologic study of 55 cases. Arch Dermatol 1968; 97:640-50
22. Carpenter S, Karpati G. Pathology of skeletal muscle. Oxford University Press, 2nd Ed., 2001:545
23. Banker BQ. Other inflammatory myopathies. In: Engel AG, Franzini-Armstrong, eds. Myology, 2nd edition. New York: Mc Graw-Hill, 1993:1461-86
24. Alegre VA, Winkelmann RK. Histiocytic cytophagic panniculitis. J Am Acad Dermatol 1989;20:177-85
25. Kumakura S, Ishikura H, Umegae N, Yamagata S, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Am J Med 1997;10:113-15
26. Papo T, Andre MH, Amoura Z, et al., The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus. J Rheumatol 1999;26:927-30
27. Yasuda S, Tsutsumi A, Nakabayashi T, et al. Haemophagocytic syndrome in a patient with dermatomyositis. Br J Rheumatol 1998;37: 1357-58
28. Laraki R, Genestie C, Wechsler J, Maisonobe T, et al. Juvenile dermatomyositis and panniculitis-type subcutaneous T-cell lymphoma. A case report. Rev Med Interne 2001;22:978-83
29. Madaule S, Porte L, Couret B, Arlet-Suau E. Fatal haemophagocytic syndrome in the course of dermatomyositis with anti-Mi2 antibodies. Rheumatology 2000;39:1157-58
30. Henter JI, Elinder G, Soder, Hansson M, Anderson B, Anderson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-22
31. Imashuku S, Hibi S, Fujiwara F, Ikushima S, Toso S. Haemophagocytotic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. Brit J Haematol 1994;88:656-58
32. Ohga S, Matsuzaki A, Nishizaki M, et al. Inflammatory cytokines in virus-associated hemophagocytic syndrome: Interferon gamma as a sensitive indicator of disease activity. Am J Pedi Hema Oncol 1993;15:291-98
33. Akashi K, Hayashi S, Gondo H, et al. Involvement of interferongamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol 1994;87:243-50
34. Thomson AW, Webster LM. The influence of cyclosporin A on cell mediated immunity. Clin Exp Immunol 1988;71:369-76
35. Benveniste O, Cherin P, Maisonobe T, et al. Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol 2001;167:3521-29
36. Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997;40:865-74
37. Tews SD, Goebel HS. Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol 1996;55: 342-47
38. Shimizu T, Tomita Y, Son K, Nishinarita S, Sawada S, Horie T. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis. Clin Rheumatol 2000;19:352-59
39. Kuru S, Inukai A, Liang Y, Doyu M, Takano A, Sobue G. Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol 2000;99:585-88
40. De Bleecker JL, Meire VI, Declercq W, Van Aken EH. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. Neuromuscul Disord 1999;9:239-46
41. Pachman L, Liotta-Davis MR, Hong DK, et al. TNFα-308A allele in juvenile dermatomyositis. Arthritis Rheum 2000;43:2368-77
42. Hull KM, Wong K, Wood GM, Chu WS, Kastner DL. Monocytic fasciitis: A newly recognized clinical feature of tumor necrosis factor receptor dysfunction, Arthritis Rheum 2002;46:2189-94
43. Harada H, Iwatsuki K, Kaneko F. Detection of Epstein-Barr virus genes in malignant lymphoma with clinical and histologic features of cytophagic histiocytic panniculitis. J Am Acad Dermatol 1994; 31:379-83
44. Cho KH, Oh JK, Kim CW, Heo DS, Kim ST. Peripheral T-cell lymphoma involving subcutaneaous tissue. Br J Dermatol 1995; 132:290-95
45. Sajben FP, Schmidt C. Subcutaneaous T-cell lymphoma: A case report and additional observations. Cutis 1996;58:297-300
46. Carli PM, Boutron MC, Maynadie M, Bailly F, Caillot D, Petrella T Increase in the incidence of non-Hodgkin's lymphomas: Evidence for a recent sharp increase in France independent of AIDS. Br J Cancer 1994;70:713-15
47. Varterasian ML, Graff JJ, Severson RK, Weiss L, al-Katib AM, Kalemkerian GP. Non-Hodgkin's lymphoma: An analysis of the Metropolitan Detroit SEER database. Cancer Invest 2000;18:303-8
48. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002;94:2015-23